ShtockMahket
5 years ago
Its valuation was (and still is!) insane, just like every other company in this sector. Sure, you can say that others (like CWBHF) are worse, but it doesn't really matter. The entire sector is getting pummeled because investors are realizing they got way ahead of themselves. There was way too much optimism reflected in valuations, and as reality continues to creep in you're obviously going to see massive moves to the downside like the one ELLXF experienced. Let's be clear: Elixinol is a disaster fundamentally. Things are getting worse every quarter. There's nothing atypical about a 75% move lower for a stock with financials this bad in a sector that was massively overheated before sentiment turned.
Again, though, I'm staying far away from this. I was dumb enough to believe in this company back when it was actually profitable and had revenue growth, and because of that I only broke even when the inevitable happened. All I can say is be careful.
ShtockMahket
5 years ago
By "unique," I mean something that doesn't apply to others in the sector. The former of your links is likely the reason for this rally, but if that is the case, I view the rally with extreme skepticism because the rest of the sector is not responding as euphorically, although there have been moderate gains. For the latter, it's hard to chalk up a 100% gain (on ASX, of course) to dog treats. Are they even new? I know they've been targeting the pet CBD market.
JohnCM
5 years ago
ELLXF
Cash on hand $37.4M as of 11/30/2019. Not bad.
What happened to Japan?
Shares outstanding 125,000,000 as of 06/12/2019 Good.
Last financials June 30, 2019??
Six months ending 6/30/2019
Loss $9,859,000
Revenue $17,455,000
Not bad. Did I miss anything? I guess we are waiting for 2019 2H results?